SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001193125-16-710276
Filing Date
2016-09-15
Accepted
2016-09-15 06:07:07
Documents
5
Effectiveness Date
2016-09-15

Document Format Files

Seq Description Document Type Size
1 DEFM14A d148907ddefm14a.htm DEFM14A 1272072
2 GRAPHIC g148907ex991pg01a.jpg GRAPHIC 11462
3 GRAPHIC g148907ex991pg01b.jpg GRAPHIC 8612
4 GRAPHIC g148907ex991pg02.jpg GRAPHIC 7057
5 GRAPHIC g148907g82q88.jpg GRAPHIC 21861
  Complete submission text file 0001193125-16-710276.txt   1341131
Mailing Address 1301 SECOND AVE. SUITE 4200 SEATTLE WA 98101
Business Address 1301 SECOND AVE. SUITE 4200 SEATTLE WA 98101 206-805-8300
ACUCELA INC. (Filer) CIK: 0001400482 (see all company filings)

IRS No.: 020592619 | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 000-55133 | Film No.: 161886205
SIC: 2834 Pharmaceutical Preparations